Skip to Main Content

Paper Details

SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.
J Nucl Med
2
2023
Author NameAffiliation
Thomas A HopeUniversity of California San Francisco
Emmanuel S AntonarakisUniversity of Minnesota Masonic Cancer Center
Jeremie CalaisDavid Geffen School of Medicine, university of california los angeles
Scott T TagawaWeill Cornell Medical College
Mary-Ellen TaplinLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Michael J MorrisMemorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2